Journal of Cataract & Refractive Surgery
Volume 30, Issue 1 , Pages 110-114 , January 2004

Outcomes of laser in situ keratomileusis in patients with pigment dispersion syndrome

  • Nada S Jabbur, MD

      Affiliations

    • Refractive Surgery Service, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • ,
  • Suhas Tuli, MD

      Affiliations

    • Refractive Surgery Service, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • ,
  • Irina S Barequet, MD

      Affiliations

    • Geldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Herzliya, Israel
    • Refractive Surgery Center, Herzliya Medical Center, Herzliya, Israel
  • ,
  • Terrence P O'Brien, MD

      Affiliations

    • Corresponding Author InformationReprint requests to Terrence P. O'Brien, MD, The Wilmer Eye Institute at Green Spring Station, 10753 Falls Road, Suite 455, Baltimore, Maryland 21093, USA.
    • Refractive Surgery Service, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

,Accepted 8 March 2003.

References 

  1. Bovell AM, Damji KF, Dohadwala AA, et al.  Familial occurrence of pigment dispersion syndrome. Can J Ophthalmol. 2001;36:11–17
  2. Lord FD, Pathanapitoon K, Mikelberg FS. Keratometry and axial length in pigment dispersion syndrome (a descriptive case-control study). J Glaucoma. 2001;10:383–385
  3. Vojnikovic B, Njiric S, Bojic L, Kovacevic D. Syndroma (glaucoma pigmentatum primarium—pigmented glaucoma). Coll Antropol. 2001;25(suppl):127–130
  4. Murrell WJ, Shihab Z, Lamberts DW, Avera B. The corneal endothelium and central corneal thickness in pigmentary dispersion syndrome. Arch Ophthalmol. 1986;104:845–846
  5. Lehto I, Ruusuvaara P, Setälä K. Corneal endothelium in pigmentary glaucoma and pigment dispersion syndrome. Acta Ophthalmol. 1990;68:703–709
  6. Wilensky JT, Buerk KM, Podos SM. Krukenberg's spindles. Am J Ophthalmol. 1975;79:220–225
  7. Hartmann C. Studies on the development of extra-endothelial and intra-endothelial pigment deposits by means of direct and indirect contact specular microscopy of the cornea. Graefes Arch Clin Exp Ophthalmol. 1982;218:75–82
  8. Farrar SM, Shields MB. Current concepts in pigmentary glaucoma. Surv Ophthalmol. 1993;37:233–252
  9. Lehto I, Vesti E. Diagnosis and management of pigmentary glaucoma. Curr Opin Ophthalmol. 1998;9:61–64
  10. Yalvaç IS, Gedikoğlu G, Karagöz Y, et al.  Effects of antiglaucoma drugs on ocular surface. Acta Ophthalmol Scand. 1995;73:246–248
  11. Niiya A, Yokoi N, Matsumoto Y, et al.  Effect of beta-blocker eyedrops on corneal epithelial barrier function. Ophthalmologica. 2000;214:332–336
  12. Arci MK, Arici DS, Topalkara A, Güler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol. 2000;28:113–117
  13. Thygesen J, Aaen K, Theodorsen F, et al.  Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension. Acta Ophthalmol Scand. 2000;78:37–41
  14. Herreras JM, Pastor JC, Calonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992;99:1082–1088
  15. Chaya C, Affeldt JC. Topical beta-blocker related neurotropic keratitis. Scientific poster 169. American Academy of Ophthalmology Final Program, 2002; 245
  16. Lass JH, Khosrof SA, Laurence JK, et al.  A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol; the Dorzolamide Corneal Effects Study Group. Arch Ophthalmol. 1998;116:1003–1010
  17. Gagnon M-M, Boisjoly HM, Brunette I, et al.  Corneal endothelial cell density in glaucoma. Cornea. 1997;16:314–318
  18. Mardelli PG, Piebenga LW, Matta CS, et al.  Corneal endothelial status 12 to 55 months after excimer laser photorefractive keratectomy. Ophthalmology. 1995;102:544–548 discussion by PS Binder, 548–549
  19. McDonald MB, Deitz MR, Frantz JM, et al.  Photorefractive keratectomy for low-to-moderate myopia and astigmatism with a small-beam, tracker-directed excimer laser. Ophthalmology. 1999;106:1481–1488 discussion by RD Stulting, 1488–1489
  20. Shaikh NM, Shaikh S, Singh K, Manche E. Progression to end-stage glaucoma after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28:356–359
  21. Kook MS, Lee S, Tchah H, et al.  Effect of laser in situ keratomileusis on retinal nerve fiber layer thickness measurements by scanning laser polarimetry. J Cataract Refract Surg. 2002;28:670–675
  22. Weiss HS, Rubinfeld RS, Anderschat JF. LASIK-associated visual field loss in a glaucoma suspect. Arch Ophthalmol. 2001;119:774–775
  23. Bushley DM, Parmley VC, Paglen P. Visual field defect associated with laser in situ keratomileusis. Am J Ophthalmol. 2000;129:668–671
  24. Duch S, Serra A, Castanera J, et al.  Tonometry after laser in situ keratomileusis treatment. J Glaucoma. 2001;10:261–265
  25. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Study (OHTS) Group; the Ocular Hypertension Study (OHTS). Ophthalmology. 2001;108:1779–1788

 Presented in part at the ASCRS Symposium on Cataract, IOL and Refractive Surgery, Philadelphia, Pennsylvania, USA, June 2002.

☆☆ None of the authors has a financial interest in any product mentioned.

PII: S0886-3350(03)00519-4

doi: 10.1016/S0886-3350(03)00519-4

Journal of Cataract & Refractive Surgery
Volume 30, Issue 1 , Pages 110-114 , January 2004